Filing Details
- Accession Number:
- 0001123292-17-001501
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-04 16:42:22
- Reporting Period:
- 2017-10-03
- Accepted Time:
- 2017-10-04 16:42:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 881524 | Vivus Inc | VVUS | Pharmaceutical Preparations (2834) | 943136179 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1640688 | T Santosh Varghese | C/O Vivus, Inc. 900 E. Hamilton Ave., Suite 550 Campbell CA 95008 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-10-03 | 434 | $0.97 | 72,740 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sold to pay the tax liability resulting from the vesting of 919 restricted stock units granted on January 23, 2015.
Billionaire Hedge Funds
